Waskell L, Canova-Davis E, Philpot R, Parandoush Z, Chiang J Y
Drug Metab Dispos. 1986 Nov-Dec;14(6):643-8.
The hepatic microsomal metabolism of methoxyflurane in rabbits is markedly stimulated by treatment with phenobarbital. However, the increased rate of metabolism cannot be completely accounted for by the activity of the purified phenobarbital-inducible cytochrome P-450 isozyme 2, even in the presence of cytochrome b5. The discovery of a second hepatic phenobarbital-inducible cytochrome P-450, isozyme 5, led us to undertake experiments to determine in hepatic and pulmonary preparations the portion of microsomal metabolism of methoxyflurane catalyzed by cytochrome P-450 isozymes 2 and 5. We report herein that isozyme 2 accounts for 25% and 29%, respectively, of the O-demethylation of methoxyflurane in hepatic microsomes from untreated and phenobarbital-treated rabbits, and for 25% of the methoxyflurane metabolism in pulmonary microsomes. Results for isozyme 5 indicate that it catalyzes 19% and 27% of methoxyflurane metabolism in control and phenobarbital-induced liver, and 47% of O-demethylation in the lung. In summary, we demonstrate that methoxyflurane O-demethylation in lung, phenobarbital-induced liver, and control liver microsomes is catalyzed by cytochrome P-450 isozymes 2 and 5. Results with purified cytochrome P-450 isozyme 5 are consistent with those obtained using microsomal preparations. Furthermore, metabolism of methoxyflurane by purified isozyme 5 is markedly stimulated by cytochrome b5. A role for cytochrome b5 in cytochrome P-450 isozyme 5-catalyzed metabolism of methoxyflurane was also demonstrated in microsomes. Antibody to isozyme 5 was unable to inhibit methoxyflurane metabolism in the presence of maximally inhibiting concentrations of cytochrome b5 antibody.(ABSTRACT TRUNCATED AT 250 WORDS)
用苯巴比妥处理家兔后,甲氧氟烷在其肝脏微粒体中的代谢受到显著刺激。然而,即便存在细胞色素b5,代谢速率的增加也不能完全由纯化的苯巴比妥诱导型细胞色素P-450同工酶2的活性来解释。第二种肝脏苯巴比妥诱导型细胞色素P-450同工酶5的发现,促使我们开展实验,以确定在肝脏和肺组织制剂中,细胞色素P-450同工酶2和5催化的甲氧氟烷微粒体代谢部分。我们在此报告,同工酶2分别占未处理和苯巴比妥处理家兔肝脏微粒体中,甲氧氟烷O-脱甲基反应的25%和29%,以及肺微粒体中甲氧氟烷代谢的25%。同工酶5的结果表明,它在对照和苯巴比妥诱导的肝脏中催化19%和27%的甲氧氟烷代谢,在肺中催化47%的O-脱甲基反应。总之,我们证明,肺、苯巴比妥诱导的肝脏和对照肝脏微粒体中的甲氧氟烷O-脱甲基反应由细胞色素P-450同工酶2和5催化。纯化的细胞色素P-450同工酶5的结果与使用微粒体制剂获得的结果一致。此外,纯化的同工酶5催化的甲氧氟烷代谢受到细胞色素b5的显著刺激。在微粒体中也证明了细胞色素b5在细胞色素P-450同工酶5催化的甲氧氟烷代谢中的作用。在存在最大抑制浓度的细胞色素b5抗体时,同工酶5抗体无法抑制甲氧氟烷代谢。(摘要截短于250字)